Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study
Jiazhuo Tang(Wuhan University), Bicheng Zhang(University of Electronic Science and Technology of China), Jiaxin Yin(Wuhan University), Yuxiao Song(Wuhan University), Fu Yang(Hubei University of Chinese Medicine), Jun Wang(South China Agricultural University), Hugo Arasanz(Navarrabiomed)
Cited by 5
Related Papers
Graphene and graphene oxide: biofunctionalization and applications in biotechnology
|Trends in biotechnology|2011|1.5k
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Vasculogenic mimicry in carcinogenesis and clinical applications
|Journal of Hematology & Oncology|2020|350